<DOC>
<DOCNO>
EP-0010617
</DOCNO>
<TEXT>
<DATE>
19800514
</DATE>
<IPC-CLASSIFICATIONS>
C07D-405/04 A61P-37/00 C07D-401/04 C07D-213/55 A61K-31/425 A61K-31/4427 C07D-409/00 A61K-31/42 C07D-213/00 A61K-31/415 C07D-417/04 A61P-37/06 C07D-403/00 C07D-405/00 A61K-31/44 C07D-409/04 C07D-417/00 A61K-31/40 <main>C07D-401/04</main> C07D-401/00 C07D-413/04 C07D-403/04 C07D-413/00 A61K-31/443 A61K-31/505 A61K-31/4433 A61P-29/00 
</IPC-CLASSIFICATIONS>
<TITLE>
novel 2-substituted-3-heterocyclylindoles, their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
schering corpus<sep>schering corporation<sep>schering corporation2000 galloping hill roadkenilworth new jersey 07033us<sep>schering corpus<sep>schering corporation<sep>
</APPLICANT>
<INVENTOR>
steinman martin<sep>tahbaz pirouz<sep>steinman, martin<sep>tahbaz, pirouz<sep>steinman, martin46 glendale avenuelivingston, new jersey 07039us<sep>tahbaz, pirouz96 oak drivecedar grove, new jersey 07009us<sep>steinman, martin<sep>tahbaz, pirouz<sep>steinman, martin46 glendale avenuelivingston, new jersey 07039us<sep>tahbaz, pirouz96 oak drivecedar grove, new jersey 07009us<sep>
</INVENTOR>
<ABSTRACT>
2-substituted-3-heterocyclyl-indoles of the formula    wherein x is a hydrogen or halogen atom,   n is 1, 2 or 3 (when x is halogen atom),   q is an oxygen atom or the group (h, oh),   z is a hydrogen atom or, provided that q is an oxygen  atom, z can also be the group or, wherein r is a hydroÂ­ gen atom or a lower alkyl or loweralkoxy-loweralkyl group,  m is 1 or 2 when z is a hydrogen atom and m is o when  z is the group or,   and het is a heterocyclic radical selected from pyridyl,  lower-alkyl-substituted pyridyl, pyrimidinyl, pyridazinyl,  pyrazinyl, pyrazolyl, imidazolyl, thiazolyl, isothiazolyl,  thienyl, furanyl, pyrrolyl, oxazolyl and isoxazolyl,   have immuno-suppressant activity and can be used for  example in the treatment of rheumatoid arthritis.  their preparation and pharmaceutical compositions  containing them are also described.  
</ABSTRACT>
</TEXT>
</DOC>
